Centre de Documentation Campus Montignies
Horaires :
Lundi : 8h-18h30
Mardi : 8h-17h30
Mercredi 9h-16h30
Jeudi : 8h-18h30
Vendredi : 8h30-12h30 et 13h-14h30
Attention,
Votre centre de documentation sera fermé ce lundi 26 août.
Également, ce mercredi 28 août il sera fermé de 12 à 13h.
Enfin, ce jeudi 29 août il ouvrira à 14h45.
Lundi : 8h-18h30
Mardi : 8h-17h30
Mercredi 9h-16h30
Jeudi : 8h-18h30
Vendredi : 8h30-12h30 et 13h-14h30
Attention,
Votre centre de documentation sera fermé ce lundi 26 août.
Également, ce mercredi 28 août il sera fermé de 12 à 13h.
Enfin, ce jeudi 29 août il ouvrira à 14h45.
Bienvenue sur le catalogue du centre de documentation du campus de Montignies.
Détail de l'auteur
Auteur Arne Decramer |
Documents disponibles écrits par cet auteur
![](./images/expand_all.gif)
![](./images/collapse_all.gif)
![Tris disponibles](./images/orderby_az.gif)
Effectiveness and safety of collagenase Clostridium histolyticum in Dupuytren’s disease : an observational study in Belgium / Frederik Verstreken in Acta Orthopaedica Belgica, Vol.82/2 (June 2016)
[article]
Titre : Effectiveness and safety of collagenase Clostridium histolyticum in Dupuytren’s disease : an observational study in Belgium Type de document : texte imprimé Auteurs : Frederik Verstreken ; Ilse Degreef ; Arne Decramer ; [et al...] Année de publication : 2016 Article en page(s) : p. 397-404 Langues : Anglais (eng) Mots-clés : maladie de Dupuytren collagène Résumé : Dupuytren’s disease is a connective tissue disorder leading to contractures. It can be treated surgically or through injections of collagenase Clostridium histolyticum (CCH). Patients with Dupuytren’s contracture (> 20°) and a palpable cord were included in this observational study, aiming to characterise the Belgian patient population and to assess the effectiveness and safety of CCH. Overall, 108 patients (114 joints) received at least one injection of CCH, and 104 patients completed the study. The percentages of joints achieving a degree of contracture of 5° or less, or a relative contracture reduction of at least 50% after the extension procedure were 64.9% and 90.1%, respectively. The mean number of injections per cord was 1.0. The Unité Rhumatologique des Affections de la Main score decreased from 29.4 ± 11.0 to 12.9 ± 6.3 (mean ± SD ; p < 0.0001). CCH was demonstrated to be effective, safe and able to increase quality of life. Permalink : ./index.php?lvl=notice_display&id=46251
in Acta Orthopaedica Belgica > Vol.82/2 (June 2016) . - p. 397-404[article] Effectiveness and safety of collagenase Clostridium histolyticum in Dupuytren’s disease : an observational study in Belgium [texte imprimé] / Frederik Verstreken ; Ilse Degreef ; Arne Decramer ; [et al...] . - 2016 . - p. 397-404.
Langues : Anglais (eng)
in Acta Orthopaedica Belgica > Vol.82/2 (June 2016) . - p. 397-404
Mots-clés : maladie de Dupuytren collagène Résumé : Dupuytren’s disease is a connective tissue disorder leading to contractures. It can be treated surgically or through injections of collagenase Clostridium histolyticum (CCH). Patients with Dupuytren’s contracture (> 20°) and a palpable cord were included in this observational study, aiming to characterise the Belgian patient population and to assess the effectiveness and safety of CCH. Overall, 108 patients (114 joints) received at least one injection of CCH, and 104 patients completed the study. The percentages of joints achieving a degree of contracture of 5° or less, or a relative contracture reduction of at least 50% after the extension procedure were 64.9% and 90.1%, respectively. The mean number of injections per cord was 1.0. The Unité Rhumatologique des Affections de la Main score decreased from 29.4 ± 11.0 to 12.9 ± 6.3 (mean ± SD ; p < 0.0001). CCH was demonstrated to be effective, safe and able to increase quality of life. Permalink : ./index.php?lvl=notice_display&id=46251 Exemplaires (1)
Cote Support Localisation Section Disponibilité Revue Revue Centre de Documentation HELHa Campus Montignies Armoires à volets Document exclu du prêt - à consulter sur place
Exclu du prêt